Categories
- PROTAC Linker
- Protein Control Ligand
- Pathway Inhibitors
- Function Modulators
- Activators
- G Protein-Coupled Receptor Ligands
- Nuclear Receptor Ligands
- GDNF Receptors
- TNF Receptors
- Transcription Factors
- Chemokines
- Cytokine Receptors
- Biomarkers and Buffer Solutions
- Molecular Probes
- Stem Cell Research
- Alzheimer's Disease
- Apoptosis
- Cancer Research
- Epigenetics
- Metabolites
- PET/SPECT Imaging Precursors
- Customized Screening Library
- Ultra Pure Pharmacological Standard
- Tissue Microarray (TMA)
- Proteins and Antibodies
- Primary Cells
- ELISA KIT
- Natural Products
- Lab Equipments
- Humanized Mice for PDX Platform
- Rare Chemicals
- Custom Synthesis
- Antibacterial
- Antifungal
- Antioxidant
- Antiviral
- Molecular Glues
- SARS-CoV
Quantity Discount Table - Order More To Get More Price Discount
| Quantity | mg | Unit Price ($/mg or $/Unit) | Final Price |
|---|---|---|---|
| 1 | 5 | $22.10 | Total: $110.50 |
| 1 | 10 | $18.72 | Total: $187.20 |
| 1 | 25 | $15.86 | Total: $396.50 |
| 1 | 50 | $13.52 | Total: $676.00 |
| 1 | 100 | $11.70 | Total: $1,170.00 |
Overview
YHO-13351 is an ABCG2 inhibitor, an acrylonitrile derivative, that induces sensitization of cancer steminitiating-like side population cells to irinotecan.GSK1702934A can be used to study diabetes.
Chemical Properties
| Molecular Formula | C27H37N3O7S2 |
| Molecular Weight | 579.73 |
| CAS Numbers | 1346753-00-1 |
| Solubility | DMSO |
| Purity | 98% by HPLC |
| SMILES Code | S(C)(=O)(=O)O.C(=C(C#N)C1=CC(OC)=C(OC)C=C1)C=2SC(=CC2)N3CCC(OC(CN(CC)CC)=O)CC3 |
Storage and Handling
0C Short Term, -20C Long Term
References
Yamazaki R, et al. Novel acrylonitrile derivatives, YHO-13177 and YHO-13351, reverse BCRPABCG2-mediated drug resistance in vitro and in vivo. Mol Cancer Ther. 2011 Jul;10[7] 1252-63.